Berthony Deslouches, MD, PhD, is a Research Assistant Professor at the University of Pittsburg. Berthony holds a Medical Doctor Degree and a Doctorate Degree in Microbiology after completing a ten-year joint Medical Scientist Training Program offered by the University of Pittsburgh School of Medicine and Carnegie Mellon University in 2008. He is a research scientist currently conducting research that focuses on the development of engineered antimicrobial peptides (eCAPs) for applications to hard-to-treat bacterial infections, particularly infections caused by multidrug-resistant pathogens. He also holds a master’s degree in Biochemistry. He attended CUNY-City College of New York where he earned an undergraduate degree in Biochemistry, Anthropology, African Studies, and Education. He currently serves as a Research Assistant Professor at the Department of Microbiology and Molecular genetics, University of Pittsburgh School of Medicine. Berthony also attended the Faculté de Médecine de Port-au-Prince for three years prior to moving to the United States. Berthony’s publications include: (2007) De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother, (2005) Antimicrobial peptides in mucosal secretions: the importance of local secretions in mitigating infection, (2005) De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity, (2005) Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications, (2003) Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model, and(2003) A heme-deficient strain of Escherichia coli has a three-base pair deletion in a “hotspot” in hemA.